Harvest Portfolios Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $52M | Buy |
99,000
+16,076
| +19% | +$8.44M | 1.21% | 33 |
|
2025
Q1 | $52.6M | Buy |
82,924
+11,555
| +16% | +$7.33M | 1.55% | 20 |
|
2024
Q4 | $50.8M | Buy |
71,369
+27,029
| +61% | +$19.3M | 1.7% | 23 |
|
2024
Q3 | $46.6M | Sell |
44,340
-7,046
| -14% | -$7.41M | 1.55% | 26 |
|
2024
Q2 | $54M | Sell |
51,386
-4,568
| -8% | -$4.8M | 2.06% | 11 |
|
2024
Q1 | $53.9M | Sell |
55,954
-5,047
| -8% | -$4.86M | 2.1% | 13 |
|
2023
Q4 | $53.6M | Sell |
61,001
-3,601
| -6% | -$3.16M | 2.27% | 13 |
|
2023
Q3 | $53.2M | Sell |
64,602
-4,659
| -7% | -$3.83M | 2.51% | 7 |
|
2023
Q2 | $49.8M | Buy |
69,261
+4,504
| +7% | +$3.24M | 2.28% | 15 |
|
2023
Q1 | $53.2M | Buy |
64,757
+5,294
| +9% | +$4.35M | 2.61% | 6 |
|
2022
Q4 | $42.9M | Buy |
+59,463
| New | +$42.9M | 2.47% | 17 |
|